Overview: The DHF is a key element of Design Control under the GMPs, and is a major subject for review during a U.S FDA compliance audit.
The EU’s MDD Technical File / Design Dossier serve a different purpose, showing conformity to the MDD and associated applicable standards and the rationale for the CE mark. Each is subject to different requirements and expectations on the part of the reviewer / auditor. As such they are compiled differently, requiring differing mindsets and documentation.
Areas Covered in the Session:
The U.S. FDA’s Design Control expectations
The DHF’s defined purpose
The EU MDD’s Technical File / Design Dossier’s defined purpose
Similarities and differences – a key to understanding
Some parallel approaches to file development
The team approach
Differing audit approaches by the FDA and your NB
Living documents
Q&A
Who Will Benefit:
Senior management, project leaders
Regulatory affairs
Quality systems personnel
Internal and supplier auditor personnel
R&D and engineering staff
Other personnel involved with activities, documentation and audits involving cGMP and/or ISO QMS activities